Pre-exposure prophylaxis (or PrEP) is a medication people at risk for HIV take to prevent getting HIV. It is not a vaccine, but it is a highly effective preventative method recommended by the World Health Organization (WHO). Studies have shown that PrEP reduces the risk of getting HIV from sex by about 99% when taken daily. This demonstration project will be provided to 250 Men who have sex with men (MSM) and Transgender Women (TGW) in the Colombo District.

The PrEP Demonstration project is implemented by the National STD and AIDS Control Program (NSACP) with the support of the Global Fund. The National Program and the Regional grant are providing support for the implementation by helping to connect community members and providing workshops to better educate MSM and TGW on PrEP. FPA will also provide support to create demand for PrEP to help the demonstration project be successful. Based on the finding the NSACP will gradually incorporate PrEP across their clinics.